Screener
Pacira BioSciences, Inc. PCRX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
FAQ
- What is Pacira BioSciences, Inc.'s EBITDA margin?
- Pacira BioSciences, Inc. (PCRX) reported EBITDA margin of 15.7% in Q1 2026.
- What is the long-term trend for Pacira BioSciences, Inc.'s EBITDA margin?
- Over 3 years (2020 to 2025), Pacira BioSciences, Inc.'s EBITDA margin has grown at a -0.5% compound annual growth rate (CAGR), from 15.4% to 15.2%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Pacira BioSciences, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude